Selected article for: "cc NC ND International license and secondary infection"
Author: Ru Liu; Xiaoyan Ming; Ou Xu; Jianli Zhou; Hui Peng; Ning Xiang; Jiaming Zhang; Hong Zhu
Title: Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data
  • Document date: 2020_3_3
    • ID: 9lissxsy_28
    Snippet: There were 40 cases (97.6%) received at least one kind of antiviral drugs empirically including oseltamivir, ribavirin, arbidol or lopinavir/ritonavir (Kaletra), which were accessible clinically in China. Antibiotics or anti-fungus drugs were applied in 95.1% cases regarding to confirmed secondary infection or preventing secondary infection in relatively severe cases. Corticosteroid was used in 78.0% cases to control immune overreaction. Human al.....
    Document: There were 40 cases (97.6%) received at least one kind of antiviral drugs empirically including oseltamivir, ribavirin, arbidol or lopinavir/ritonavir (Kaletra), which were accessible clinically in China. Antibiotics or anti-fungus drugs were applied in 95.1% cases regarding to confirmed secondary infection or preventing secondary infection in relatively severe cases. Corticosteroid was used in 78.0% cases to control immune overreaction. Human albumin was applied when serum albumin decreased below 30g/L. Immunoglobulin was also applied empirically, as well as . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral drug and International license: 1, 2, 3
    • antiviral drug and lopinavir arbidol: 1, 2, 3, 4
    • antiviral drug and secondary infection: 1
    • case apply and secondary infection: 1
    • cc NC ND International license and human albumin: 1, 2
    • cc NC ND International license and International license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc NC ND International license and lopinavir arbidol: 1
    • cc NC ND International license and relatively severe case: 1
    • cc NC ND International license and secondary infection: 1, 2, 3
    • human albumin and International license: 1, 2
    • human albumin and secondary infection: 1, 2
    • International license and lopinavir arbidol: 1
    • International license and relatively severe case: 1
    • International license and secondary infection: 1, 2, 3
    • lopinavir arbidol and secondary infection: 1